ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved..
We dedicate this manuscript in memory of a dear friend and colleague Bella Kaufman. The fifth International Consensus Symposium for Breast Cancer in Young Women (BCY5) took place virtually in October 2020, organized by the European School of Oncology (ESO) and the European Society of Medical Oncology (ESMO). Consensus recommendations for the management of breast cancer in young women were updated from BCY4 with incorporation of new evidence to inform the guidelines. Areas of research priorities as well as specificities in different geographic and minority populations were identified. This manuscript summarizes the ESO-ESMO international consensus recommendations, which are also endorsed by the European Society of Breast Specialists (EUSOMA).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 33(2022), 11 vom: 25. Nov., Seite 1097-1118 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Paluch-Shimon, S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breast cancer |
---|
Anmerkungen: |
Date Completed 01.11.2022 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.annonc.2022.07.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344536343 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344536343 | ||
003 | DE-627 | ||
005 | 20231226023010.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.annonc.2022.07.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1148.xml |
035 | |a (DE-627)NLM344536343 | ||
035 | |a (NLM)35934170 | ||
035 | |a (PII)S0923-7534(22)01858-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Paluch-Shimon, S |e verfasserin |4 aut | |
245 | 1 | 0 | |a ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.11.2022 | ||
500 | |a Date Revised 29.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a We dedicate this manuscript in memory of a dear friend and colleague Bella Kaufman. The fifth International Consensus Symposium for Breast Cancer in Young Women (BCY5) took place virtually in October 2020, organized by the European School of Oncology (ESO) and the European Society of Medical Oncology (ESMO). Consensus recommendations for the management of breast cancer in young women were updated from BCY4 with incorporation of new evidence to inform the guidelines. Areas of research priorities as well as specificities in different geographic and minority populations were identified. This manuscript summarizes the ESO-ESMO international consensus recommendations, which are also endorsed by the European Society of Breast Specialists (EUSOMA) | ||
650 | 4 | |a Practice Guideline | |
650 | 4 | |a Journal Article | |
650 | 4 | |a breast cancer | |
650 | 4 | |a fertility | |
650 | 4 | |a young women | |
700 | 1 | |a Cardoso, F |e verfasserin |4 aut | |
700 | 1 | |a Partridge, A H |e verfasserin |4 aut | |
700 | 1 | |a Abulkhair, O |e verfasserin |4 aut | |
700 | 1 | |a Azim, H A |e verfasserin |4 aut | |
700 | 1 | |a Bianchi-Micheli, G |e verfasserin |4 aut | |
700 | 1 | |a Cardoso, M J |e verfasserin |4 aut | |
700 | 1 | |a Curigliano, G |e verfasserin |4 aut | |
700 | 1 | |a Gelmon, K A |e verfasserin |4 aut | |
700 | 1 | |a Gentilini, O |e verfasserin |4 aut | |
700 | 1 | |a Harbeck, N |e verfasserin |4 aut | |
700 | 1 | |a Kaufman, B |e verfasserin |4 aut | |
700 | 1 | |a Kim, S B |e verfasserin |4 aut | |
700 | 1 | |a Liu, Q |e verfasserin |4 aut | |
700 | 1 | |a Merschdorf, J |e verfasserin |4 aut | |
700 | 1 | |a Poortmans, P |e verfasserin |4 aut | |
700 | 1 | |a Pruneri, G |e verfasserin |4 aut | |
700 | 1 | |a Senkus, E |e verfasserin |4 aut | |
700 | 1 | |a Sirohi, B |e verfasserin |4 aut | |
700 | 1 | |a Spanic, T |e verfasserin |4 aut | |
700 | 1 | |a Sulosaari, V |e verfasserin |4 aut | |
700 | 1 | |a Peccatori, F |e verfasserin |4 aut | |
700 | 1 | |a Pagani, O |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 33(2022), 11 vom: 25. Nov., Seite 1097-1118 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2022 |g number:11 |g day:25 |g month:11 |g pages:1097-1118 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2022.07.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2022 |e 11 |b 25 |c 11 |h 1097-1118 |